Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Bioactive Compounds

Bioactive Compounds

Items 9941-9950 of 13441

Page
per page
  1. L-798,106
    B7371 L-798,106
    Summary: prostanoid EP3 receptor antagonist
      ≥54.2 mg/mL
  2. PE 154
    B7585 PE 154
    Summary: human acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) inhibitor
      <29.48 mg/mL
  3. RP 001 hydrochloride
    B7634 RP 001 hydrochloride
    Target: S1P receptors
    Summary: S1P1 receptor agonist
      <43.25 mg/mL
  4. L002
    B7739 L002
    Summary: p300 inhibitor
      Soluble in DMSO
  5. RSVA 405
    B7759 RSVA 405
    Summary: AMPK activator
      <15.62 mg/mL
  6. MLN2238
    A4008 MLN2238
     3 Citation
    Summary: β5 site of the 20S proteasome inhibitor
  7. Apoptosis Activator 2
    A4016 Apoptosis Activator 2
    Summary: Indoledione caspase activator, cell-permeable
      Soluble in DMSO
  8. Radicicol
    A4067 Radicicol
     5 Citation
    Summary: ATPase/kinase inhibitor
      Soluble in ethanol
  9. Tofacitinib (CP-690550) Citrate
    A4135 Tofacitinib (CP-690550) Citrate
     6 Citation
    Target: JAK
    Summary: Potent JAK inhibitor
      ≥25.22 mg/mL
  10. Raltegravir (MK-0518)
    A4073 Raltegravir (MK-0518)
     1 Citation
    Target: integrase
    Summary: HIV-1 integrase inhibitor
      insoluble in EtOH; insoluble in H2O; ≥19.95 mg/mL

Items 9941-9950 of 13441

Page
per page